| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
36 companies
Orbimed Advisors LLC is a Director, 10% Owner at EWTX with holdings across 36 companies. Recent SEC Form 4 filings include 21 buys and 0 sells.
Estimated insider holdings value: $2080.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 24, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 1,000 | $12.98 | $12,983.00 | - | |
| Jun 21, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 38,383 | $12.75 | $489,192.21 | +0.4% | |
| Jun 16, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 20,000 | $12.35 | $247,000.00 | +0.1% | |
| Jun 10, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 50,000 | $12.96 | $648,100.00 | +0.5% | |
| May 24, 2016 | Director | Buy | 1,712,400 | $10.42 | $17,849,568.00 | +2.0% | ||
| May 20, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 4,716 | $13.09 | $61,732.44 | - | |
| May 19, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director | Buy | 6,800 | $11.77 | $80,035.04 | - | |
| May 11, 2016 | NTLA Intellia Therapeutics, Inc. | Director | Buy | 250,000 | $18.00 | $4,500,000.00 | +5.0% | |
| Mar 29, 2016 | CRVS Corvus Pharmaceuticals, Inc. | Director, 10% Owner | Buy | 550,000 | $15.00 | $8,250,000.00 | +11.7% | |
| Jul 6, 2015 | PVLA Palvella Therapeutics, Inc. | Director, 10% Owner | Buy | 500,000 | $2.75 | $1,375,000.00 | +7.4% |